Prognosis of patients with renal carcinoma has improved since the advent of targeted therapies.
These last years, due to the improvement of patients overall survival, the incidence of brain metastasis among renal carcinoma patients has increased. This worsens the prognosis of patients. The present revue aims to do a point on treatment of brain metastasis from renal carcinoma. It will address both locoregional (surgery, radiotherapy and stereotactic radiosurgery) and systemic (targeted therapies) treatments.
Written by:
Teghom C, Giraud P, Menei P, Medioni J, Elaidi R, Combe P, Oudard S. Are you the author?
Hôpital européen Georges-Pompidou, service de cancérologie médicale, 20, rue Leblanc, 75015 Paris, France.
Reference: Bull Cancer. 2012 Jun;99(6):627-34.
PubMed Abstract
PMID: 22645282
Article in French.
UroToday.com Renal Cancer Section
